![](/img/cover-not-exists.png)
Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study
Vibeke Strand, David Fiorentino, ChiaChi Hu…Volume:
11
Language:
english
DOI:
10.1186/1477-7525-11-82
Date:
December, 2013
File:
PDF, 457 KB
english, 2013